| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |